The European Parliament today voted to endorse the outcome of trilogue negotiations on the EU’s proposed legislation for genetically modified plants developed using so-called new genomic techniques (NGTs). Under the new rules, many plants engineered with gene editing techniques such as CRISPR/Cas will fall outside EU GMO law, meaning requirements for environmental risk assessment, traceability measures and consumer labelling will no longer apply.









